There are 11 resources available
Welcome and introduction
Presenter: John Haanen
Session: Welcome and introduction
Resources:
Presentation
Webcast
What every medical oncologist should know about Tumour Immunology
Presenter: John Haanen
Session: Welcome and introduction
Resources:
Presentation
Webcast
State-of-the-art: Immunotherapy with Immune Check Point Inhibitors of Locally Advanced and Metastatic Non-Small Cell Lung Cancer in 1st and later lines
Presenter: Maurice Pérol
Session: Session 1
Resources:
Presentation
Webcast
Debate Pro: one size fits all!
Presenter: Maurice Pérol
Session: Session 2: Are all fit patients candidates for 1st-line treatment with Immune Check Point Inhibitors?
Resources:
Presentation
Webcast
Debate Contra: Patients should be selected based on predictive biomarkers
Presenter: David Planchard
Session: Session 2: Are all fit patients candidates for 1st-line treatment with Immune Check Point Inhibitors?
Resources:
Presentation
Webcast
In TPS>50%, what is best in 1st-line: single agent Pembrolizumab or CT-IO combination?
Presenter: Solange Peters
Session: Session 3
Resources:
Presentation
Webcast
What is the rational for adding anti-angiogenics to Immune Check-Point Inhibitors?
Presenter: Solange Peters
Session: Session 4
Resources:
Presentation
Webcast
The point of view of the Immunologist
Presenter: John Haanen
Session: Session 5: Refining patient selection: Immuno-score, -profiling, -gram and Tumor Mutation Burden
Resources:
Presentation
Webcast
Brain metastasis as a target
Presenter: Aurélien Marabelle
Session: Session 6: Efficacy evaluation of Immune Check Points Inhibitors: Recist 1.1, iRecist or Ir Recist? The issue and risk of hyper-progression
Resources:
Presentation
Webcast
Use of checkpoint inhibitors in patients with AID and chronic viral infections
Presenter: Aurélien Marabelle
Session: Session 7
Resources:
Presentation
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.